Idioma: Español
Referencias bibliográficas: 6
Paginas: 172-174
Archivo PDF: 70.50 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kappos L, Radue EW, Burtin P, et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010; 20.

2. Cohen JA, Barkhof F, Kappos L, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010.

3. Giovannoni G, Comi G, Greenberg SJ, et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med 2010.

4. Kruit MC, van Buchem MA, Launer LJ, Terwindt JM, and Ferrari MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA study. Cephalalgia 2010; 30(2): 129-36.

5. Boeve BF. Progress on Progranulin Arch Neurol 2010; 67(2): 145-8.

6. Yu C-E, Bird TD, Bekris LM, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 2010; 67(2): 161-70.